Spektron Systems is happy to present Q-MAP, the Quantum-Molecular Activity Predictor. This machine learning platform is built for the development of novel molecules for Best-In-Class drug therapies. Working with small-molecules, our platform provides an atom-by-atom resolution of a chemical space around a drug class. By analyzing this space from multiple viewpoints of efficacy, toxicity, and side-effects, we seek to create an optimal molecular structure that improves the drug class overall.
Below is the link to a presentation given 7/10/19 in NYC. It contains more technical information than originally presented. We are happy to discuss these details with any interested person.
For more information and questions – contact Rob Cain, Chief Strategy Officer, EVP, and Board Member